FDA Grants Full Approval of Pfizer-BioNTech V...

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. A selloff in stocks and bonds was trimmed as assurances on American action to secure shipping lanes through the Strait of Hormuz amid the Iran war pa ...  Show more

Money manager Danny Moses, immortalized in The Big Short, said last week that private credit and private equity firms’ push into retail products reminds him of the years preceding the subprime mortgage crisis. The comments, made during a panel at the iConnections Global Alts conf ...  Show more

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ...  Show more

An official rollout of Covid-19 vaccine booster doses could begin within weeks, pending FDA authorization. The Biden administration has had internal conversations about scaling back the ambitious booster plan laid out by federal health officials. The Pfizer/BioNTech booster plan ...  Show more

The Food and Drug Administration has authorized a vaccine by Pfizer and BioNTech that will start reaching the most at-risk Americans today. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks through the final hurdles the vaccine had to clear over the weekend. To learn more ab ...  Show more

Bloomberg Opinion Columnist and Former New York Fed President William Dudley discusses the outlook for the labor market and Fed monetary policy. David Riley, BlueBay Asset Management Chief Investment Strategist, says the market is underpricing the Fed. Danny Blanchflower, Dartmou ...  Show more